Andrew M Hopkins

First-in-Human Phase 1 Study To Assess Safety, Tolerability, and Pharmacokinetics of a Novel Antifungal Drug, VL-2397, in Healthy Adults

Larry R. Smith, S. Sullivan, M. Mammen, 2019, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic-Pharmacodynamic Target Attainment Analysis to Support VL-2397 Dose Selection for a Phase 2 Trial in Patients with Invasive Aspergillosis

Larry R. Smith, S. Sullivan, M. Mammen, 2017, Open Forum Infectious Diseases.

Experiences in Academic and Industry Partnerships – Forging a Path to Translational Drug Discovery

Vadim J. Gurvich, N. Carragher, S. Frye, 2021 .